Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease
Abstract Thrombocytosis is common in sickle cell disease and may contribute to vaso‐occlusion. Hydroxyurea treats extreme thrombocytosis. Acquired von Willebrand disease should be considered prior to aspirin therapy.
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.3556 |